Latest News about REGN
Recent news which mentions REGN
From Benzinga
Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
August 26, 2025
From Benzinga
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
August 25, 2025
From Benzinga
2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts
August 24, 2025
From Motley Fool
Is This The Right Time To Consider Healthcare ETFs?
August 21, 2025
From TalkMarkets
A Look Into Regeneron Pharmaceuticals Inc's Price Over Earnings
August 11, 2025
From Benzinga
How Do Investors Really Feel About Regeneron Pharmaceuticals?
August 08, 2025
Tickers
REGN
From Benzinga
These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings
August 04, 2025
From Benzinga
Is Regeneron Pharmaceuticals Gaining or Losing Market Support?
August 04, 2025
Tickers
REGN
From Benzinga
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
August 03, 2025
From Motley Fool
Stocks Sell Off, Gold Rallies On Tariff Turmoil, Weak Jobs Data: What's Moving Markets Friday?
August 01, 2025
From Benzinga
From Benzinga
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
August 01, 2025
From Benzinga
Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
August 01, 2025
From Benzinga
Earnings Scheduled For August 1, 2025
August 01, 2025
From Benzinga
From Motley Fool
$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
July 25, 2025
From Benzinga
From Benzinga
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
July 19, 2025
From Motley Fool
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
From Benzinga
2 Beaten-Down Stocks to Buy and Hold
July 05, 2025
From Motley Fool
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma
July 03, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.